KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to 5.03.

  • Emergent BioSolutions' Interest Coverage Ratio fell 3523.56% to 5.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.99, marking a year-over-year increase of 20867.59%. This contributed to the annual value of 1.53 for FY2024, which is 8147.39% up from last year.
  • Emergent BioSolutions' Interest Coverage Ratio amounted to 5.03 in Q3 2025, which was down 3523.56% from 0.11 recorded in Q2 2025.
  • Over the past 5 years, Emergent BioSolutions' Interest Coverage Ratio peaked at 31.87 during Q4 2021, and registered a low of 12.29 during Q3 2023.
  • Over the past 5 years, Emergent BioSolutions' median Interest Coverage Ratio value was 0.64 (recorded in 2024), while the average stood at 0.24.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first skyrocketed by 90417.85% in 2021, then tumbled by 128486.82% in 2022.
  • Quarter analysis of 5 years shows Emergent BioSolutions' Interest Coverage Ratio stood at 31.87 in 2021, then plummeted by 113.56% to 4.32 in 2022, then soared by 53.28% to 2.02 in 2023, then skyrocketed by 68.2% to 0.64 in 2024, then skyrocketed by 884.07% to 5.03 in 2025.
  • Its last three reported values are 5.03 in Q3 2025, 0.11 for Q2 2025, and 3.39 during Q1 2025.